Patient-reported outcome measures: are they feasible in everyday practice?
Immunotherapy in NSCLC: a perspective
KEYNOTE-006: the efficacy of ipilimumab after pembrolizumab in patients with advanced melanoma
Erdafitinib for FGFR-mutated urothelial carcinoma
PROPHECY trial: AR-V7 CTCs as a biomarker in mCRPC